---
title: "Algernon Health Inc. (AGNPF.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/AGNPF.US.md"
symbol: "AGNPF.US"
name: "Algernon Health Inc."
industry: "Pharmaceuticals"
---

# Algernon Health Inc. (AGNPF.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.algernonhealth.com](https://www.algernonhealth.com) |

## Company Profile

Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute ...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.95 | 101/256 | 9.13 | 8.57 | 7.88 |
| PB | 1.25 | 60/256 | 1.65 | 1.38 | 1.20 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/AGNPF.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/AGNPF.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/AGNPF.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.